Nitric oxide and glutamate interaction in the control of cortical and hippocampal excitability

Epilepsia

Volumn 40, Issue 7, 1999, Pages 830-836

  Ferraro, Giuseppe ^b   Montalbano, Maria Eva ^b   La Grutta, Vittorio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE

Author keywords

Cortex; Excitability; Glutamate; Hippocampus; Nitric oxide

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 7 NITROINDAZOLE; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BIOENERGY; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SOMATOSENSORY CORTEX;

ANIMALS; CEREBRAL CORTEX; EPILEPSY; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SOMATOSENSORY CORTEX;

EID: 0001506685     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00788.x     Document Type: Article

References (50)

1. Bredt DS, Snyder SH. Nitric oxide, a novel messenger. Neuron 1992;8:3-11.
2. Snyder SH. Nitric oxide and neurons. Curr Opin Neurobiol 1992; 2:323-7.
3. Wallace MN, Tayebjee MH, Rana FS, Farquhar DA, Nyong'o AO. Pyramidal neurones in pathological human motor cortex express nitric oxide synthase. Neurosci Lett 1996;212:187-90.
4. Ingi T, Cheng J, Ronnett GV. Carbon monoxide: an endogenous modulator of the nitric oxide-cyclic GMP signalling system. Neuron 1996;16:835-42.
5. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993;364:626-32.
6. Iadecola C, Beitz AJ, Renno W, Xu X, Mayer B, Zhang F. Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvessels. Brain Res 1993;606:148-55.
7. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
8. Das I, Khan NS, Puri BK, Hirsh SR. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett 1996; 215:209-11.
9. Demas GE, Eliasson MJL, Dawson TM, et al. Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice. Mol Med 1997;3:610-6.
10. Przegaliñski E, Baran L, Siwanowicz J. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci Lett 1996;217:145-8.
11. Kabuto H, Yokoi I, Habu H, Willmore LJ, Mori A, Ogawa N, Reduction in nitric oxide synthase activity with development of an epileptogenic focus induced by ferric chloride in the rat brain. Epilepsy Res 1996;25:65-8.
12. Boda B, Szente M. Nitric oxide synthase inhibitor facilitates focal seizures induced by aminopyridine in rat. Neurosci Lett 1996;209: 37-40.
13. Kirkby DR, Carrol DM, Grossman AB, Subramanian S. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res 1996;24:91-100.
14. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 1991; 254:1503-6.
15. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991;349: 326-8.
16. Maggio R, Fumagalli F, Donati E, et al. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Res 1995;679:184-7.
17. Ferraro G, Montalbano ME, La Grutta V. NO and hippocampal epilepsy: an electrophysiological evidence of a new modulatory system. Epilepsia 1997;38:190-1.
18. Stringer JL, Erden F. In the hippocampus in vivo, nitric oxide does not appear to function as an endogenous antiepileptic agent. Exp Brain Res 1995;105:391-401.
19. Kiss JP, Sershen H, Lajtha A, Vizi ES. Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neurosci Lett 1996;215:115-8.
20. Osonoe K, Mori N, Suzuki K, Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 1994;663:338-40.
21. Penix LP, Davis W, Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res 1994;18:177-84.
22. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991;14:60-7.
23. Collingridge GL, Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 1990;11:290-7.
24. Keinänen K, Wisden W, Sommer B, et al. A family of AMPA-selective glutamate receptors. Science 1990;249:556-60.
25. Bhardwaj A, Northington FJ, Ichord RN, Hanley DF, Traystman RJ, Koehler RC. Characterization of ionotropic glutamate receptor-mediated nitric oxide production in vivo in rats. Stroke 1997;28: 850-6.
26. Brenman JE, Bredt DS. Synaptic signalling by nitric oxide. Curr Opin Neurobiology 1997;7:374-8.
27. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron 1992; 8:653-62.
28. Akira T, Henry D, Wasterlain CG. Nitric oxide mediates the sustained opening of NMDA receptor-gated ionic channels which follows transient excitotoxic exposure in hippocampal slices. Brain Res 1994;652:190-4.
29. Akira T, Henry D, Baldwin RA, Wasterlain CG. Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia. Brain Res 1994;645:285-90.
30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1986.
31. Rondouin G, Lerner-Natoli M, Manzoni O, Lafon-Cazal M, Bockaert J. A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. Neuroreport 1992;3:805-8.
32. Wang Q, Theard MA, Pellegrino DA, et al. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res 1995;658:192-8.
33. Bains JS, Ferguson AV. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of rat paraventricular nucleus. J Physiol 1997;499:733-46.
34. Pereira de Vasconcelos A, Baldwin RA, Wasterlain CG. Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proc Natl Acad Sci USA 1995;92:3175-9.
35. MacKenzie GM, Rose S, Bland-Ward PA, Moore PK, Jenner P, Marsden CD. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport 1994;5:1993-6.
36. Chaparrohuerta V, Beaszarate C, Guerrero MU, Feriavelasco A. Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem Int 1997;31:607-16.
37. Nei K, Matsuyama S, Shuntoh H, Tanaka C. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Res 1996;728:105-10.
38. Smith SE, Man CM, Yip PK, Tang E, Chapman AG, Meldrum BS. Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol 1996;119: 165-73.
39. Getting SJ, Segieth J, Ahmad S, Biggs CS, Whitton PS. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res 1996;717:196-9.
40. Bogdanov MB, Wurtman RJ. Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study. Neurosci Lett 1997;221:197-201.
41. Ayata C, Ayata G, Hara H, et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci 1997;17:6908-17.
42. Aoki C, Rhee J, Lubin M, Dawson TM. NMDA-R1 subunit of the cerebral cortex colocalizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spines. Brain Res 1997;750:25-40.
43. Aizenman E, Lipton SA, Loring RH. Selective modulation of NMDA responses by reduction and oxidation. Neuron 1989;2: 1257-63.
44. Aizenman E, Hartnett KA, Reynolds IJ. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 1990;5:841-6.
45. Quesada O, Hirsch J, Ben-Ari Y, Bernard C. Redox sites of NMDA receptors can modulate epileptiform activity in hippocampal slices from kainic acid-treated rats. Neurosci Lett 1996;212: 171-4.
46. Lei SZ, Pan ZH, Aggarwal SK, et al. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992;8:1087-99.
47. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ. Role of NO production in NMDA receptor-mediated neuro-transmitter release in cerebral cortex. Science 1994;263:973-7.
48. Sandirasegarane L, Mikler JR, Tuchek JM, Sulakhe PV. Enhanced forebrain nitric oxide synthase activity in epileptic fowl. Brain Res 1996;735:311-3.
49. Baltrons MA, García A. AMPA receptors are coupled to the nitric oxide/cyclic GMP pathway in cerebellar astroglial cells. Eur J Neurosci 1997;9:2497-501.
50. Kendrick KM, Guevara-Guzman R, De la Riva C, Christensen J, Ostergaard K, Emsno PC. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide play a neuroprotective role. Eur J Neurosci 1996;8:2619-34.